AB Science Updates On Masitinib In Multiple Sclerosis
23 Sep 2024 //
GLOBENEWSWIRE
Sanofi MS drug tolebrutinib misses goal in relapsing disease trials
02 Sep 2024 //
REUTERS
Still under partial hold, Sanofi makes case for safety of MS med
28 Apr 2023 //
FIERCE BIOTECH
Tolebrutinib clinical trial program update
08 Aug 2022 //
PRESS RELEASE
FDA sidelines Hudson`s $3.7B MS drug after establishing link to liver damage
30 Jun 2022 //
ENDPTS
Sanofi moves MS patients out of Ukraine to maintain trial
29 Apr 2022 //
FIERCEBIOTECH